Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT01351909

1 development in the corpus

NCT01351909

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 1 TRIAL

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

ClinicalTrials.gov

This is a Phase 1 dose-escalation study with no results yet posted; it addresses safety and recommended dose, not efficacy or clinical benefit.

PreliminaryLaboratory Biomarker Analysis National Cancer Institute (NCI)Metastatic Breast Carcinoma

Reported

Planned enrollment35

Study phasePhase 1

Primary outcome measureRecommended phase II dose of veliparib and…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support